0

GSK137647A

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP349085821
CAS349085-82-1
MDL NumberMFCD02007969
Molecular Weight305.39
InChI KeyFQUAFMNPXPXOJE-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Effect of GSK-137647A, the First Non-Carboxylic FFA4 Agonist, on the Osteogenic and Adipogenic Differentiation of Bone Mesenchymal Stem Cells in db/db Mice

Chunlei Wang, Yanmei Liu, Yuan Pan, Hui Jin

J Pharm Pharmacol. 2020 Mar;72(3):461-469.

PMID: 31858612

1

GPR120 Protects Lipotoxicity-Induced Pancreatic β-cell Dysfunction Through Regulation of PDX1 Expression and Inhibition of Islet Inflammation

Yi Wang, Ting Xie, Dan Zhang, Po Sing Leung

Clin Sci (Lond). 2019 Jan 11;133(1):101-116.

PMID: 30523046

1

Identification of Diarylsulfonamides as Agonists of the Free Fatty Acid Receptor 4 (FFA4/GPR120)

Steven M Sparks, Grace Chen, Jon L Collins, Dana Danger, Steven T Dock, Channa Jayawickreme, Stephen Jenkinson, Christopher Laudeman, M Anthony Leesnitzer, Xi Liang, Patrick Maloney, David C McCoy, David Moncol, etc.

Bioorg Med Chem Lett. 2014 Jul 15;24(14):3100-3.

PMID: 24881566

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode